Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:21 PM
Ignite Modification Date:
2025-12-24 @ 1:21 PM
NCT ID:
NCT03710395
Eligibility Criteria:
Inclusion Criteria:
* Chronic hypertensive breastfeeding women
* Patients being treated with 20 mg slow-release nifedipine every 12 hours for at least 15 days
Exclusion Criteria:
* Patients in use of ABCG2 inhibitors (omeprazole, pantoprazole, ritonavir, saquinavir, imatinib, efavirenz, nicardipine, abacavir, tacrolimus, ciclosporin A, cannabidiol);
* Patients who presented nifedipine adverse drug reactions
* Patients whose blood pressure normalized after delivery
* Patients who interrupted breastfeeding during the study
* Patients who did not return to the hospital for the clinical protocol.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT03710395
Study Brief:
Protocol Section:
NCT03710395